RAB11B and osteosarcoma: Since lnc-RAB11B-AS1 was revealed to inhibit proliferation, migration and invasion and promote the apoptosis of osteosarcoma cells, lnc-RAB11B-AS1 is a potential therapeutic target for osteosarcoma.